Cargando…

Diagnosis of dementia with Lewy bodies: diagnostic performance of combined (123)I-IMP brain perfusion SPECT and (123)I-MIBG myocardial scintigraphy

OBJECTIVE: We assessed the value of combining (123)I-IMP brain perfusion SPECT and (123)I-MIBG myocardial scintigraphy for the discrimination of dementia with Lewy bodies (DLB) from other types of dementia. METHODS: We subjected 252 consecutive patients with clinically suspected DLB to both (123)I-I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakamoto, Fumi, Shiraishi, Shinya, Yoshida, Morikatsu, Tomiguchi, Seiji, Hirai, Toshinori, Namimoto, Tomohiro, Hashimoto, Mamoru, Ikeda, Manabu, Uetani, Hiroyuki, Yamashita, Yasuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483188/ https://www.ncbi.nlm.nih.gov/pubmed/24363079 http://dx.doi.org/10.1007/s12149-013-0796-3

Ejemplares similares

(123)I-ioflupane brain SPECT and (123)I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders
por: Nuvoli, Susanna, et al.
Publicado: (2017)

Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ((123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout
por: Verberne, Hein J., et al.
Publicado: (2009)

Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson’s Disease
por: ASAHI, Takashi, et al.
Publicado: (2016)

Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy
por: Sato, Kenichiro, et al.
Publicado: (2016)

123I‐MIBG scintigraphy and 18F‐FDG‐PET imaging for diagnosing neuroblastoma
por: Bleeker, Gitta, et al.
Publicado: (2015)

Potential Utility of (123)I-MIBG Scintigraphy as a Predictor of Falls in Parkinson's Disease
por: Murakami, Nagahisa, et al.
Publicado: (2019)

Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review
por: Pitton Rissardo, Jamir, et al.
Publicado: (2023)

Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial (123)I-MIBG turnover can identify Lewy body disease
por: Kumakura, Yoshitaka, et al.
Publicado: (2021)

The utility of the combination of a SPECT study with [(123)I]-FP-CIT of dopamine transporters and [(123)I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes
por: Uyama, Naoto, et al.
Publicado: (2017)

Renal Function in Relation to Cardiac (123)I-MIBG Scintigraphy in Patients with Chronic Heart Failure
por: Verschure, Derk O., et al.
Publicado: (2012)

Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure
por: Veltman, Caroline E., et al.
Publicado: (2012)

Cardiac 123I-MIBG Scintigraphy in Neurodegenerative Parkinson Syndromes: Performance and Pitfalls in Clinical Practice
por: Skowronek, Cornelia, et al.
Publicado: (2019)

Bilateral adrenal uptake of (123)I MIBG scintigraphy with mild catecholamine elevation, the diagnostic dilemma, and its characteristics
por: Inaba, Yuiko, et al.
Publicado: (2022)

Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma
por: Brady, Samuel L., et al.
Publicado: (2019)

Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions
por: van der Veen, Berlinda J., et al.
Publicado: (2012)

Transformation of a nonfunctional paraganglioma with I-123 MIBG scintigraphy correlation: A case report: Notice of Retraction
Publicado: (2016)

Influence of antidepressant use on (123)I-MIBG heart and lung uptakes in the diagnosis of Lewy body disease
por: Adaniya, Shinobu, et al.
Publicado: (2022)

Author Correction: Bilateral adrenal uptake of (123)I MIBG scintigraphy with mild catecholamine elevation, the diagnostic dilemma, and its characteristics
por: Inaba, Yuiko, et al.
Publicado: (2022)

Cardiac (123)I-mIBG Imaging in Heart Failure
por: Verschure, Derk O., et al.
Publicado: (2022)

Uniformity of cardiac (123)I-MIBG uptake on SPECT images in older adults with normal cognition and patients with dementia
por: Roberts, Gemma, et al.
Publicado: (2019)

Uptake Index of (123)I-metaiodobenzylguanidine Myocardial Scintigraphy for Diagnosing Lewy Body Disease
por: Kamiya, Yoshito, et al.
Publicado: (2017)

(123)I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel
por: Lewington, V., et al.
Publicado: (2016)

The relation between cardiac (123)I-mIBG scintigraphy and functional response 1 year after CRT implantation
por: Verschure, D O, et al.
Publicado: (2020)

Can early phase cardiac [(123)I]mIBG images be used to diagnose Lewy body disease?
por: Roberts, Gemma, et al.
Publicado: (2022)

Prediction of outcomes in MCI with (123)I-IMP-CBF SPECT: a multicenter prospective cohort study
por: Ito, Kengo, et al.
Publicado: (2013)

(123)I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
por: Kitamura, Yoshiyuki, et al.
Publicado: (2021)

The prognostic value of (123)I-mIBG SPECT cardiac imaging in heart failure patients: a systematic review
por: Pontico, Mariano, et al.
Publicado: (2021)

A Simple Non-invasive I-123-IMP Autoradiography Method Developed by Modifying the Simple Non-invasive I-123-IMP Microsphere Method
por: Ofuji, Asato, et al.
Publicado: (2018)

Vascular time-activity variation in patients undergoing (123)I-MIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptake
por: Verberne, Hein J., et al.
Publicado: (2011)

(123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review
por: Chung, Eun Joo, et al.
Publicado: (2015)

Autopsy Validation of the Diagnostic Accuracy of (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease
por: Matsubara, Tomoyasu, et al.
Publicado: (2022)

Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson’s Disease: A Multicenter Study
por: De Feo, Maria Silvia, et al.
Publicado: (2023)

Investigation of the new non-invasive semi-quantitative method of (123)I-IMP pediatric cerebral perfusion SPECT
por: Wakabayashi, Yasuharu, et al.
Publicado: (2020)

Myocardial (123)I-MIBG Uptake and Cardiovascular Autonomic Function in Parkinson's Disease
por: Katagiri, Akira, et al.
Publicado: (2015)

Cardiac sympathetic activity in chronic heart failure: cardiac (123)I-mIBG scintigraphy to improve patient selection for ICD implantation
por: Verschure, D. O., et al.
Publicado: (2016)

Autonomic nervous system activity in primary Raynaud's phenomenon: Heart rate variability, plasma catecholamines and [(123)I]MIBG heart scintigraphy
por: Lindberg, Lotte, et al.
Publicado: (2021)

Impact of Diabetes on Cardiac Sympathetic Innervation in Patients With Heart Failure: A (123)I meta-iodobenzylguanidine ((123)I MIBG) scintigraphic study
por: Paolillo, Stefania, et al.
Publicado: (2013)

(123)I-MIBG Scintigraphy as a Powerful Tool to Plan an Implantable Cardioverter Defibrillator and to Assess Cardiac Resynchronization Therapy in Heart Failure Patients
por: Stefanelli, Antonella, et al.
Publicado: (2012)

Myocardial (123)I-mIBG scintigraphy in relation to markers of inflammation and long-term clinical outcome in patients with stable chronic heart failure
por: Verschure, Derk O., et al.
Publicado: (2016)

A European myocardial (123)I-mIBG cross-calibration phantom study
por: Verschure, Derk O., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e8rnablp1h1703m5thn0cia1eq